<SEC-DOCUMENT>0001171843-18-002166.txt : 20180321
<SEC-HEADER>0001171843-18-002166.hdr.sgml : 20180321
<ACCEPTANCE-DATETIME>20180321171205
ACCESSION NUMBER:		0001171843-18-002166
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180321
FILED AS OF DATE:		20180321
DATE AS OF CHANGE:		20180321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RedHill Biopharma Ltd.
		CENTRAL INDEX KEY:			0001553846
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35773
		FILM NUMBER:		18705130

	BUSINESS ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
		BUSINESS PHONE:		972-3-541-3131

	MAIL ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k_032118.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES&nbsp;</B>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C.&nbsp;20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Rule 13a-16 or 15d-16</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of&nbsp;the Securities Exchange Act of
1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of March 2018<BR>
Commission File No.:001-35773</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REDHILL BIOPHARMA LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name
into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>21 Ha'arba'a Street, Tel Aviv, 64739,
Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">Indicate by check
mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 14.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 14.2pt">Form 20-F &#9746;&nbsp;Form
40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 14.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">Indicate by check
mark if the Registrant is&nbsp;submitting&nbsp;the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">Indicate by check
mark if the Registrant is&nbsp;submitting&nbsp;the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attached hereto and incorporated herein
by reference is the notice of annual general meeting of the Company posted by the Company on its website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Signatures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">Pursuant to the requirements
of&nbsp;the&nbsp;Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 30%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">REDHILL BIOPHARMA LTD.</font></TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>(the &quot;Registrant&quot;)</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Date: March 21, 2018</TD>
    <TD STYLE="border-bottom: Black 1pt solid">By: /s/ <I>Dror Ben-Asher</I>&nbsp;&nbsp; </TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Dror Ben-Asher&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="logo.jpg" ALT="" STYLE="height: 66.8pt; width: 112.45pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 21, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 16pt; background-color: white"><B><U>Notice
of Annual General Meeting of Shareholders</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>REDHILL
BIOPHARMA LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>(</B>the
<B>&ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Annual General
Meeting of Shareholders of RedHill Biopharma Ltd. (the &ldquo;Company&rdquo;), will be held at the offices of the Company, 21 Ha'arba'a
Street, Floor 16, Tel-Aviv, Israel on May 2, 2018 at 3:00 p.m. Israel time, or at any adjournments thereof (the &ldquo;<B>General
Meeting</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>The agenda of the meeting shall
be as follows:</U>&#9; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">1.</TD><TD STYLE="text-align: justify">To appoint Kesselman &amp; Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers
International Limited, as the Company&rsquo;s auditors for the year 2018 and for an additional period until the next Annual General
Meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2017;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">2.</TD><TD STYLE="text-align: justify">To approve an increase of the authorized share capital of the Company by 300 million Ordinary Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">3.</TD><TD STYLE="text-align: justify">To approve the re-election of Mr. Ofer Tsimchi, Dr. Kenneth Reed and Mr. Eric Swenden to the board
of directors of the Company (the &quot;<B>Board of Directors</B>&quot;), each for an additional three-year term until the annual
general meeting to be held in 2021;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">4.</TD><TD STYLE="text-align: justify">To approve grant of 500,000 options to purchase Ordinary Shares of the Company to Mr. Dror Ben-Asher,
the Company&rsquo;s Chief Executive Officer and Chairman of the Board of Directors;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">5.</TD><TD STYLE="text-align: justify">To approve extension of options to purchase ordinary shares in the Company granted to Mr. Dror
Ben-Asher, the Company&rsquo;s Chief Executive Officer and Chairman of the Board of Directors;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">6.</TD><TD STYLE="text-align: justify">To approve extension of options to purchase ordinary shares in the Company granted to Mr. Ofer
Tsimchi, a non-executive director of the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.5pt"></TD><TD STYLE="width: 19.85pt">7.</TD><TD STYLE="text-align: justify">To approve an amendment to the Company's Amended and Restated Award Plan (2010).</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">In addition, shareholders
at the General Meeting will have an opportunity to review and ask questions regarding the financial statements of the Company for
the fiscal year ended December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">Only holders of record
of ordinary shares, par value NIS 0.01 per share (the &ldquo;Ordinary Shares&rdquo;), and holders of record of ADSs, evidenced
by American Depositary Receipts issued by The Bank of New York Mellon, shall be entitled to receive notice of and to vote at the
General Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">The record date for
determining the right of a shareholder of the Company to participate and vote at the Meeting will be the end of the business day
on Monday, March 26, 2018 (the &ldquo;<B>Record Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The approval of Proposals
1, 2, 3, 6 and 7 each requires the affirmative vote of at least a majority of the voting power represented at the General Meeting,
in person or by proxy, and voting on the matter presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">The approval of Proposals
4 and 5 each requires the affirmative vote of at least a majority of the voting power represented at the General Meeting, in person
or by proxy, and voting on the matter presented, provided that one of the following two alternatives must apply: (i) such majority
vote at the General Meeting shall include at least a majority of the total votes of shareholders who are not controlling shareholders
of the Company (as defined in the Companies Law) and do not have a personal interest in the approval of the proposal, participating
in the voting at the General Meeting in person or by proxy, without taking abstentions into account; or (ii) the total number of
votes of the non-controlling shareholders mentioned in clause (i) above that are voted against such proposal does not exceed two
percent (2%) of the total voting rights in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">Shareholders registered
in the Company's shareholders register in Israel and shareholders who hold Ordinary Shares through members of the Tel-Aviv Stock
Exchange may also vote through a proxy card to be provided by the Company, by completing, dating, signing and mailing the proxy
to the Company's offices so that it is received by the Company no later than Wednesday, May 2, 2018, at 11:00 a.m. Israel time.
Shareholders registered in the Company's shareholders register in Israel and shareholders who hold Ordinary Shares through members
of the Tel-Aviv Stock Exchange who vote their Ordinary Shares by proxy must also provide the Company with a copy of their identity
card, passport or certification of incorporation, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">Shareholders who
hold Ordinary Shares through members of the Tel-Aviv Stock Exchange and intend to vote their Ordinary Shares either in person or
by proxy must deliver to the Company, no later than Wednesday, May 2, 2018, at 11:00 a.m. Israel time, an ownership certificate
confirming their ownership of the Company&rsquo;s Ordinary Shares on the Record Date, which certificate must be approved by a recognized
financial institution, as required by the Israeli Companies Regulations (Proof of Ownership of Shares for Voting at General Meeting)
of 2000, as amended. Alternatively, shareholders who hold Ordinary Shares through members of the Tel-Aviv Stock Exchange may vote
electronically via the electronic voting system of the Israel Securities Authority up to four hours before the time fixed for the
General Meeting (<I>i.e</I>., 11 a.m. Israel time on May 2, 2018). You should receive instructions about electronic voting from
the Tel-Aviv Stock Exchange member through which you hold your Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">ADS holders should
return their proxies by the date set forth on the form of proxy to be provided to them by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">Shareholders wishing
to express their position on an agenda item for this General Meeting may do so by submitting a written statement (&ldquo;Position
Statement&rdquo;) to the Company&rsquo;s offices, c/o Mr. Micha Ben Chorin, at 21 Ha'arba'a Street, Tel-Aviv, 64739 Israel, by
no later than April 22, 2018. Any Position Statement received, that is in accordance with the guidelines set by the Israel Companies
Law, will be furnished to the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on Form 6-K, and will be made
available to the public on the Commission&rsquo;s website at <U>http://www.sec.gov</U> and in addition at <U>http://www.magna.isa.gov.il</U>
or <U>http://maya.tase.co.il</U>..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;Postponement
of Meeting - If within half an hour from the time appointed for the Meeting a quorum is not present, the Meeting shall be adjourned
to the next business day following the day of the scheduled Meeting, at the same time and place, or at another day, time and place
prescribed by the Board of Directors in a notification to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">This Notice and the
documents mentioned therein, as well as the proposed resolutions on the agenda, can be viewed at the Company's registered office
on 21 Ha'arba'a Street, Tel-Aviv, Tel: +972 3 541 3131, Sunday through Thursday between 10:00-15:00, and also will be made available
to the public on the Commission&rsquo;s website at <U>http://www.sec.gov</U> and in addition at <U>http://www.magna.isa.gov.il</U>
or <U>http://maya.tase.co.il</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">By Order of the Board of Directors,</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><B>Dror Ben-Asher</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><B>Chairman of the Board of Directors</B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RedHill Biopharma Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<HR NOSHADE SIZE="4" STYLE="color: Black; width: 100%; margin-top: 3pt; margin-bottom: 3pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #, 5@# 2(  A$! Q$!_\0
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M%6,]CY_&Y96P:4JEFGV-&BBBM#SPHHHH **** "BBB@ HHHH **** "BBB@
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MO93S*!N1"PS["L;2;F74H)7E5,HP VC%1'GY&^AZGUFC]8@I*\[.S\C,U/\
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M$LCD<HAY5!Z<8)]_H*X/XQ9U'XI6-BY^00P0_P#?3DG_ -"KZ$\E50*H 4#
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M3_T\K_Z"U2^%X=WABR;'56_]"-3_ !.BV>'(#_T]+_Z"U6?!\.[PC8-ZJ_\
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M*"W_ #%U_P# ?_[*O2:*/JU+L4LRQ*^U^"/,&^$);_F,K_X#?_95"_P:+_\
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M(W,9_P#'2OY5G:WIJZA\9?#KN,I:6$UP1[AL#\BP/X4 ;_A?PTFAVTES=/\
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M^;$UU-% &/9^$_#NGR"2TT/3H9!T=+9 P_'&:RK;'_"V-0 [:-!_Z-DKK"0
M22 !U)KS;P=JK:W\4-?U%!_H<MG&MHW]^))&3</8LKD?6@#TJBBB@ K@+;4=
M2\/>)_$;'PUJU]#>7:3136J(5*B)%[L.X-=_10!R/_":W_\ T)?B'_OU%_\
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=%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
